CreditReports.dk
HomeScreen companies

NMD Pharma A/S Financials, key figures and credit report

CVR number: 36899069 Established 2015 Industry: 72 Scientific research and development
Company contact details
Palle Juul-Jensens Boulevard 82, 8200 Aarhus N
Gross profit -26 063.2 kEUR FY 2025 +6.2% vs 2024
EBIT -34 082.7 kEUR FY 2025 -0.7% vs 2024
Net debt -21 308.5 kEUR FY 2025 +43.8% vs 2024
Quick ratio 6.3 FY 2025 -3.5 vs 2024

Income statement (kEUR)

2021
2022
2023
2024
2025
Fiscal period length1212121212
Net sales
Gross profit-11 029.05-9 480.44-18 817.94-27 797.96-26 063.18
Employee benefit expenses-3 223.88-3 499.79-4 403.80-6 019.35-7 965.69
Total depreciation-18.92-35.91-53.83
EBIT-14 252.93-12 980.23-23 240.65-33 853.22-34 082.70
Other financial income107.50921.18516.81
Other financial expenses-97.72-80.32-4.84-58.22- 156.05
Pre-tax profit-14 350.64-13 060.55-23 138.00-32 990.26-33 721.93
Income taxes736.56736.56736.56736.56736.56
Net earnings-13 614.08-12 323.99-22 401.44-32 253.70-32 985.37

Assets (kEUR)

2021
2022
2023
2024
2025
Intangible assets total
Buildings27.68
Machinery and equipment94.61160.60124.70193.48
Tangible assets total94.61160.60124.70221.16
Holdings in group member companies0.000.000.000.00
Investments total0.000.00129.99208.58
Non-current other receivables80.9182.61121.29
Long term receivables total80.9182.61121.29
Inventories total
Current amounts owed by group member comp.67.94182.47
Prepayments and accrued income16.9336.16100.9960.68
Current other receivables286.45319.04277.58220.35246.41
Current deferred tax assets736.56736.56736.56736.56736.56
Short term receivables total1 023.011 140.481 050.311 057.901 226.12
Cash and bank deposits3 815.8325 820.8645 060.4238 081.1121 349.15
Cash and cash equivalents3 815.8325 820.8645 060.4238 081.1121 349.15
Balance sheet total (assets)4 919.7527 138.5646 392.6339 393.6923 005.02

Equity and liabilities (kEUR)

2021
2022
2023
2024
2025
Share capital226.46394.10576.55690.59736.26
Share premium account34 704.0011 674.21
Retained earnings15 983.2037 062.8564 497.7532 253.7032 985.37
Profit of the financial year-13 614.08-12 323.99-22 401.44-32 253.70-32 985.37
Shareholders equity total2 595.5825 132.9742 672.8735 394.5912 410.48
Non-current other liabilities201.31
Non-current deferred tax liabilities7 003.36
Non-current liabilities total201.317 003.36
Current loans from credit institutions14.5931.8118.1410.9140.62
Current trade creditors1 669.171 526.023 016.392 943.022 530.09
Current owed to group member76.80158.58
Other non-interest bearing current liabilities439.10447.77608.42886.591 020.47
Current liabilities total2 122.852 005.603 719.753 999.103 591.18
Balance sheet total (liabilities)4 919.7527 138.5646 392.6339 393.6923 005.02
Page generated